Background: Malignant peripheral nerve sheath tumor (MPNST) is a heterogeneous group of neoplasms that shows divergent differentiation potential, and the cytological findings are largely nonspecific. There are no previous reports specifically alluding to the cytological findings of MPNST showing fibroblastic differentiation (fibroblastic MPNST). Case: A 59-year-old woman with neurofibromatosis type 1 developed a rapidly enlarging tumor on the scalp. A metastatic lesion in the ileum was examined cytologically. Irregularly shaped clusters of spindle cells with wavy or buckled nuclei and fibrillary cytoplasm were found as well as many similar isolated cells. Histopathologically, the tumor showed a spindle cell sarcomatous appearance typical of MPNST. Immunohistochemically, the tumor cells were negative for S-100 protein and epithelial membrane antigen but immunoreactive for vimentin, CD10 and CD34. Ultrastructurally, the tumor cells were not invested by the basal lamina and had abundant rough-surfaced endoplasmic reticulum and a subplasmalemmal accumulation of microfilaments with dense patches. These immunohistochemical and ultrastructural findings were consistent with fibroblastic or myofibroblastic differentiation. Conclusion: Although there are no cytological findings specific for fibroblastic MPNST, the wide spectrum of differentiation in MPNST should be kept in mind during cytological examination of soft tissue sarcomas.

Keywords:
Malignant peripheral nerve sheath tumor, Fibroblastic differentiation, Cytology
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.